Resource use and costs associated with routine management of febrile neutropenia in German hospitals

被引：0
|
作者：
Ihbe-Heffinger, Angela [1 ]
Paessens, Bernadette [1 ]
Jacobs, Volker R. [2 ]
Ehlken, Birgit [3 ]
Shlaen, Margarita [3 ]
Berger, Karin [3 ]
Bernard, Rudolf [1 ]
Peschel, Christian [4 ]
Goertz, Anita [5 ]
von Schilling, Christoph [6 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Pharm, D-8000 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol, D-8000 Munich, Germany
[3] Med Econ Res Grp GmbH, Munich, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-8000 Munich, Germany
[5] Amgen GmbH, Munich, Germany
[6] Klinikum Freising, Dept Med 3, Freising Weihenstephan, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3338.3338
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3338
引用
收藏
页码：980A / 980A
页数：1
相关论文
共 50 条
  • [1] RESOURCE USE AND COSTS ASSOCIATED WITH ROUTINE MANAGEMENT OF CHEMOTHERAPY RELATED TOXICITY IN GERMAN HOSPITALS
    Paessens, B.
    von Schilling, C.
    Ehiken, B.
    Shlaen, M.
    Berger, K.
    Bernard, R.
    Peschel, C.
    Ihbe-Heffinger, A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 272 - 272
  • [2] Costs Associated with Febrile Neutropenia in the US
    Michels, Shannon L.
    Barron, Rich L.
    Reynolds, Matthew W.
    Tomic, Karen Smoyer
    Yu, Jingbo
    Lyman, Gary H.
    [J]. PHARMACOECONOMICS, 2012, 30 (09) : 809 - 823
  • [3] Costs Associated with Febrile Neutropenia in the US
    Shannon L. Michels
    Rich L. Barron
    Matthew W. Reynolds
    Karen Smoyer Tomic
    Jingbo Yu
    Gary H. Lyman
    [J]. PharmacoEconomics, 2012, 30 : 809 - 823
  • [4] THE COSTS OF TREATING FEBRILE NEUTROPENIA IN 6 UK HOSPITALS
    LEESE, B
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A : S15 - S18
  • [5] Febrile neutropenia in lymphoma patients is associated with substantial resource use and healthcare costs in clinical practice in Spain.
    Lopez, A.
    Alonso, J. D.
    Gomez-Codina, J.
    Novo, A.
    Herrera, C.
    Lara, N.
    Gasquet, J. A.
    Sanchez, J.
    [J]. BLOOD, 2006, 108 (11) : 475B - 475B
  • [6] An analysis of the resource use and costs of febrile neutropenia events in pediatric cancer patients in Australia
    Vargas, Constanza M.
    Haeusler, Gabrielle A.
    Slavin, Monica E.
    Babl, Franz
    Mechinaud, Francoise
    Phillips, Robert
    Thursky, Karin
    Lourenco, Richard De Abreu
    Australian PICNICC Study Grp
    [J]. PEDIATRIC BLOOD & CANCER, 2023,
  • [7] Management of chemotherapy-associated febrile neutropenia
    D Cameron
    [J]. British Journal of Cancer, 2009, 101 : S18 - S22
  • [8] Management of chemotherapy-associated febrile neutropenia
    Cameron, D.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 : S18 - S22
  • [9] Direct costs associated with febrile neutropenia in inpatients with hematological diseases in Singapore
    Yvonne Peijun Zhou
    Jing Jin
    Ying Ding
    Yen Lin Chee
    Liang Piu Koh
    Wee Joo Chng
    Douglas Su-Gin Chan
    Li Yang Hsu
    [J]. Supportive Care in Cancer, 2014, 22 : 1447 - 1451
  • [10] DIRECT COSTS ASSOCIATED WITH NEUTROPENIA AND FEBRILE NEUTROPENIA AS ADVERSE EVENTS OF CHEMOTHERAPY IN SERBIAN CANCER PATIENTS
    Lukic, S.
    Desnica, J.
    Stefanovic, K.
    Kostic, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S455 - S455
12345